Compare CRBP & TII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CRBP | TII |
|---|---|---|
| Founded | 2009 | 2012 |
| Country | United States | Canada |
| Employees | N/A | 167 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 184.4M | 219.2M |
| IPO Year | 2014 | N/A |
| Metric | CRBP | TII |
|---|---|---|
| Price | $9.27 | $2.17 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 2 |
| Target Price | ★ $45.50 | $6.38 |
| AVG Volume (30 Days) | 467.9K | ★ 1.1M |
| Earning Date | 05-08-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,822,272.00 | N/A |
| Revenue This Year | N/A | $4.20 |
| Revenue Next Year | $116.00 | $3.46 |
| P/E Ratio | ★ N/A | $25.66 |
| Revenue Growth | ★ 97.62 | N/A |
| 52 Week Low | $7.12 | $1.81 |
| 52 Week High | $20.56 | $5.65 |
| Indicator | CRBP | TII |
|---|---|---|
| Relative Strength Index (RSI) | 57.06 | 46.42 |
| Support Level | $7.42 | $1.99 |
| Resistance Level | $9.57 | $2.44 |
| Average True Range (ATR) | 0.50 | 0.28 |
| MACD | 0.21 | 0.02 |
| Stochastic Oscillator | 87.14 | 27.01 |
Corbus Pharmaceuticals Holdings Inc is a clinical stage company focused on new therapies in oncology and obesity and is committed to helping people defeat serious illness by bringing inventive scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.
Titan Mining Corp is a Canadian natural resources company. The company is engaged in the acquisition, exploration, development, and extraction of mineral properties. The company owns an interest in the Empire State Mine in Northern New York State, United States, and Kilbourne Graphite Project. The Company operates one reportable segment, mineral production and exploration in the United States.